Literature DB >> 30726838

A Retrospective Review of Dupilumab for Hand Dermatitis.

Nicole Lee1, Naina Chipalkatti1, Pedro Zancanaro2, Courtney Kachuk2, Nicole Dumont2, David Rosmarin3.   

Abstract

Entities:  

Keywords:  Atopic dermatitis; Dupilumab; Hand dermatitis

Mesh：

Substances：

Year:  2019        PMID： 30726838     DOI： 10.1159/000496481

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  3 in total

1.  Three cases of non-atopic hyperkeratotic hand eczema treated with dupilumab.

Authors:  Laura Loman; Gilles F H Diercks; Marie L A Schuttelaar
Journal:  Contact Dermatitis       Date:  2020-10-01       Impact factor: 6.600

2.  The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis-52 week results from the Dutch BioDay Registry.

Authors:  Angelique N Voorberg; Geertruida L E Romeijn; Marjolein S de Bruin-Weller; Marie L A Schuttelaar
Journal:  Contact Dermatitis       Date:  2022-04-24       Impact factor: 6.419

3.  Vesicular hand eczema transcriptome analysis provides insights into its pathophysiology.

Authors:  Angelique N Voorberg; Hanna Niehues; Jart A F Oosterhaven; Geertruida L E Romeijn; Ivonne M J J van Vlijmen-Willems; Piet E J van Erp; Thomas H A Ederveen; Patrick L J M Zeeuwen; Marie L A Schuttelaar
Journal:  Exp Dermatol       Date:  2021-07-21       Impact factor: 3.960
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.